Norio Iwaki

1.1k total citations
39 papers, 779 citations indexed

About

Norio Iwaki is a scholar working on Epidemiology, Infectious Diseases and Endocrine and Autonomic Systems. According to data from OpenAlex, Norio Iwaki has authored 39 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Endocrine and Autonomic Systems. Recurrent topics in Norio Iwaki's work include Influenza Virus Research Studies (36 papers), Respiratory viral infections research (35 papers) and Pneumonia and Respiratory Infections (10 papers). Norio Iwaki is often cited by papers focused on Influenza Virus Research Studies (36 papers), Respiratory viral infections research (35 papers) and Pneumonia and Respiratory Infections (10 papers). Norio Iwaki collaborates with scholars based in Japan and Belgium. Norio Iwaki's co-authors include Hideyuki Ikematsu, Naoki Kawai, Seizaburo Kashiwagi, Nobuo Hirotsu, Takashi Kawashima, Tetsunari Maeda, S Kashiwagi, Kiyomitsu Miyachi, Satoshi Yamauchi and Kenichi Kawamura and has published in prestigious journals such as Clinical Infectious Diseases, Vaccine and International Journal of Infectious Diseases.

In The Last Decade

Norio Iwaki

39 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Norio Iwaki Japan	13	727	174	97	74	54	39	779
Yu Mao China	6	400 0.6×	195 1.1×	36 0.4×	71 1.0×	24 0.4×	11	523
Kwok‐Hung Chan Hong Kong	15	596 0.8×	193 1.1×	43 0.4×	100 1.4×	17 0.3×	22	651
Murray Kimmel United States	4	461 0.6×	147 0.8×	63 0.6×	117 1.6×	11 0.2×	5	604
Hannah E. Maier United States	10	227 0.3×	219 1.3×	119 1.2×	54 0.7×	18 0.3×	18	493
Claudio Giuseppe Molteni Italy	10	275 0.4×	110 0.6×	44 0.5×	97 1.3×	37 0.7×	13	420
Steven R. Mostow United States	15	401 0.6×	127 0.7×	68 0.7×	103 1.4×	21 0.4×	39	566
Adrian R Tramontana Australia	7	367 0.5×	237 1.4×	24 0.2×	38 0.5×	49 0.9×	12	468
Jarika Makkoch Thailand	10	326 0.4×	134 0.8×	122 1.3×	114 1.5×	19 0.4×	20	481
Mahesh Moorthy India	10	216 0.3×	161 0.9×	46 0.5×	35 0.5×	55 1.0×	37	373
Timothy M. Straight United States	10	253 0.3×	119 0.7×	60 0.6×	48 0.6×	24 0.4×	12	390

Countries citing papers authored by Norio Iwaki

Since Specialization

Citations

This map shows the geographic impact of Norio Iwaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norio Iwaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norio Iwaki more than expected).

Fields of papers citing papers by Norio Iwaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norio Iwaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norio Iwaki. The network helps show where Norio Iwaki may publish in the future.

Co-authorship network of co-authors of Norio Iwaki

This figure shows the co-authorship network connecting the top 25 collaborators of Norio Iwaki. A scholar is included among the top collaborators of Norio Iwaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norio Iwaki. Norio Iwaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tani, Naoki, Naoki Kawai, Yong Chong, et al.. (2021). Susceptibility of epidemic viruses to neuraminidase inhibitors and treatment-emergent resistance in the Japanese 2019-20 influenza season. Journal of Infection. 84(2). 151–157. 7 indexed citations

Ikematsu, Hideyuki, Naoki Kawai, Naoki Tani, et al.. (2020). In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018–19 season: Comparison with the 2010–11 to 2017–18 seasons. Journal of Infection and Chemotherapy. 26(8). 775–779. 11 indexed citations

Ikematsu, Hideyuki, et al.. (2019). In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season: Comparison with the 2010–11 to 2016–17 seasons. Journal of Infection and Chemotherapy. 25(8). 649–652. 6 indexed citations

Ikematsu, Hideyuki, Naoki Kawai, Norio Iwaki, & Seizaburo Kashiwagi. (2016). Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate for influenza treatment; comparison among the four Japanese influenza seasons from 2011–2012 to 2014–2015. Journal of Infection and Chemotherapy. 22(9). 605–610. 8 indexed citations

Ikematsu, Hideyuki, et al.. (2015). In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013–2014 season. Journal of Infection and Chemotherapy. 21(9). 634–638. 15 indexed citations

Ikematsu, Hideyuki, Naoki Kawai, Norio Iwaki, & Seizaburo Kashiwagi. (2014). In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012–2013 season. Journal of Infection and Chemotherapy. 21(1). 39–42. 21 indexed citations

Ikematsu, Hideyuki, Naoki Kawai, Norio Iwaki, & Seizaburo Kashiwagi. (2013). The duration of fever and other symptoms after the initiation of laninamivir octanoate hydrate in the Japanese 2011–2012 influenza season. Journal of Infection and Chemotherapy. 20(2). 81–85. 12 indexed citations

Ikematsu, Hideyuki, Naoki Kawai, Norio Iwaki, & Seizaburo Kashiwagi. (2013). In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011–2012 season in Japan. Journal of Infection and Chemotherapy. 20(2). 77–80. 16 indexed citations

Kawai, Naoki, Hideyuki Ikematsu, Takashi Kawashima, et al.. (2012). Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B. Influenza and Other Respiratory Viruses. 7(3). 448–455. 9 indexed citations

10.

Kashiwagi, S, et al.. (2012). Clinical efficacy of long-acting neuraminidase inhibitor, laninamivir octanoate hydrate, in postmarketing surveillance. International Journal of Infectious Diseases. 16. e88–e88. 1 indexed citations

11.

Ikematsu, Hideyuki, Yuriko Takeuchi, Mats Rosenlund, et al.. (2011). The post‐infection outcomes of influenza and acute respiratory infection in patients above 50 years of age in Japan: an observational study. Influenza and Other Respiratory Viruses. 6(3). 211–217. 11 indexed citations

12.

Kawai, Naoki, Tetsunari Maeda, Satoshi Yamauchi, et al.. (2010). Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007–2008 and 2008–2009 seasons. Journal of Infection and Chemotherapy. 17(3). 375–381. 13 indexed citations

13.

Kawai, Naoki, Hideyuki Ikematsu, Norio Iwaki, et al.. (2009). Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation. Journal of Infection. 59(3). 207–212. 48 indexed citations

14.

Kawai, Naoki, Hideyuki Ikematsu, Norio Iwaki, et al.. (2008). Detection of Respiratory Syncytial Virus with Nested RT-PCR and a New Rapid Detection Test Kit in Patients with Influenza-like Illness, Including Elderly Adults. Kansenshogaku zasshi. 82(1). 1–5. 1 indexed citations

15.

Kawai, Naoki, Hideyuki Ikematsu, Norio Iwaki, et al.. (2007). A change in the effectiveness of amantadine for the treatment of influenza over the 2003–2004, 2004–2005, and 2005–2006 influenza seasons in Japan. Journal of Infection and Chemotherapy. 13(5). 314–319. 9 indexed citations

16.

Kawai, Naoki, Hideyuki Ikematsu, Norio Iwaki, et al.. (2007). Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. Journal of Infection. 55(3). 267–272. 57 indexed citations

17.

Kawai, Naoki, et al.. (2006). A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003-2004 and 2004-2005 Influenza Seasons. Clinical Infectious Diseases. 43(4). 439–444. 138 indexed citations

18.

Kawai, Naoki, Norio Iwaki, Takashi Kawashima, et al.. (2004). Clinical Symptoms of Influenza Infection in the 2002-2003 Season. Kansenshogaku zasshi. 78(8). 681–689. 3 indexed citations

19.

Kawai, Naoki, Hideyuki Ikematsu, Norio Iwaki, et al.. (2004). The clinical outcomes of anti-influenza drug therapy: a Japanese multi-center study of the 2002–2003 influenza season. International Congress Series. 1263. 507–510. 3 indexed citations

20.

Kawai, Naoki, Norio Iwaki, Takashi Kawashima, et al.. (2003). Effectiveness of Oseltamivir on Influenza and Influencing Factors. Kansenshogaku zasshi. 77(6). 423–429. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact